Desk Notes | ILA ILA – Galidesivir Cleared for Compassionate Use in the Bundibugyo Ebola Outbreak Bynathan@prenzlergroup.com.au 07/07/202613/08/2026
ILA | Research (ASX:ILA) Island Pharmaceuticals – Regulatory Alignment and Strategic Partnerships Accelerate Galidesivir Toward Animal Rule Approval Bynathan@prenzlergroup.com.au 04/03/202613/08/2026
ILA | Research (ASX:ILA) Island Pharmaceuticals – FDA Confirms Animal Rule Pathway for Galidesivir Bynathan@prenzlergroup.com.au 17/11/202513/08/2026
ILA | Research (ASX:ILA) Island Pharmaceuticals – FDA Meeting Granted Bynathan@prenzlergroup.com.au 09/10/202513/08/2026
ILA | Research (ASX:ILA) Island Pharmaceuticals – Two Shots at a Billion-Dollar Prize in Antivirals Bynathan@prenzlergroup.com.au 26/08/202513/08/2026
